OCGN
Ocugen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.79
+0.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 31.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -16.13x
- Price / sales
- 58.29x
- Price / cash flow
- -4.36x
Enterprise value
- Enterprise value
- $254.9M
- EV / sales
- 55.66x
- EV / EBITDA
- -3.64x
- EV / EBIT
- -3.70x
- Market cap
- $267.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026